Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and neostigmine

1-methyl-4-phenylpyridinium has been researched along with neostigmine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H1
Atadzhanov, MA; Kryzhanovskiĭ, GN; Nerobkova, LN; Voronina, TA1

Other Studies

2 other study(ies) available for 1-methyl-4-phenylpyridinium and neostigmine

ArticleYear
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution

2011
[The characteristics of a parkinsonian syndrome induced in an experiment by a deficiency of nigrostriatal dopamine and by stimulation of the cholinergic neurons of the caudate nucleus].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1993, Volume: 93, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetylcholine; Animals; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Electroencephalography; Male; Neostigmine; Neurons; Oxotremorine; Parkinson Disease, Secondary; Rats; Receptors, Cholinergic; Substantia Nigra

1993